Boston Scientific Corp/ US1011371077 /
| 2024-04-26 9:55:51 PM | Chg. -0.08 | Volume | Bid9:55:51 PM | Ask9:55:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 73.21USD | -0.10% | 268,021 Turnover: 19.64 mill. |
73.20Bid Size: 200 | 73.21Ask Size: 200 | 107.38 bill.USD | - | 67.77 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2,079 | 2,084 | 2,252 | 2,446 | 2,859 | ||||||
| Intangible Assets | 7,886 | 5,917 | 6,121 | 5,902 | 6,003 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 25,866 | 24,083 | 25,912 | 26,709 | 28,622 | ||||||
| Inventories | 1,579 | 1,351 | 1,610 | 1,867 | 2,484 | ||||||
| Accounts Receivable | 1,828 | 1,531 | 1,778 | 1,970 | 2,228 | ||||||
| Cash and Cash Equivalents | 217 | 1,734 | 1,925 | 928 | 865 | ||||||
| Current Assets | 4,699 | 6,694 | 6,317 | 5,760 | 6,514 | ||||||
| Total Assets | 30,565 | 30,777 | 32,229 | 32,469 | 35,136 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 542 | 513 | 794 | 862 | 942 | ||||||
| Long-term debt | 8,592 | 9,130 | 8,804 | 8,915 | 8,571 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 595 | 330 | 310 | - | - | ||||||
| Liabilities | 16,688 | 15,451 | 15,607 | 14,896 | 15,606 | ||||||
| Share Capital | 16 | 17 | 17 | 17 | 17 | ||||||
| Total Equity | 13,877 | 15,326 | 16,622 | 17,573 | 19,530 | ||||||
| Minority Interests | - | - | - | - | 248 | ||||||
| Total liabilities equity | 30,565 | 30,777 | 32,229 | 32,469 | 35,136 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 10,735 | 9,913 | 11,888 | 12,682 | 14,240 | ||||||
| Depreciation (total) | 699 | 789 | 741 | 803 | 828 | ||||||
| Operating Result | 1,518 | -80 | 1,199 | 1,649 | 2,343 | ||||||
| Interest Income | -473 | -361 | -341 | -470 | -265 | ||||||
| Income Before Taxes | 687 | -79 | 1,076 | 1,141 | 1,985 | ||||||
| Income Taxes | -4,013 | 2 | 36 | 443 | 393 | ||||||
| Minority Interests Profit | - | - | - | - | -1 | ||||||
| Net Income | 4,700 | -115 | 985 | 642 | 1,570 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,836 | 1,508 | 1,870 | 1,526 | 2,503 | ||||||
| Cash Flow from Investing Activities | -5,041 | -411 | -1,597 | -2,011 | -2,574 | ||||||
| Cash Flow from Financing | 2,973 | 293 | -95 | -548 | 5 | ||||||
| Decrease / Increase in Cash | -222 | 1,388 | 173 | -1,042 | -70 | ||||||
| Employees | 36,000 | 38,000 | 41,000 | - | - | ||||||
